Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi.

Autor: Cavazza A; Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, WC1N 1EH London, UK., Hendel A; Institute of Nanotechnology and Advanced Materials, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel., Bak RO; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Rio P; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), 28040 Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain., Güell M; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Integra Therapeutics S.L., Barcelona, Spain., Lainšček D; Department of Synthetic Biology and Immunology, National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia., Arechavala-Gomeza V; Nucleic Acid Therapeutics for Rare Disorders (NAT-RD), Biobizkaia Health Research Institute, Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Peng L; Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer, 13288 Marseille, France., Hapil FZ; Department of Medical Biology and Genetics, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Harvey J; Institute of Ophthalmology, University College London, London, UK., Ortega FG; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Avenida de la Ilustración 114, 18016 Granada, Spain.; IBS Granada, Institute of Biomedical Research, Avenida de Madrid 15, 18012 Granada, Spain., Gonzalez-Martinez C; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Avenida de la Ilustración 114, 18016 Granada, Spain.; IBS Granada, Institute of Biomedical Research, Avenida de Madrid 15, 18012 Granada, Spain., Lederer CW; Department of Molecular Genetics Thalassaemia, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Mikkelsen K; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark., Gasiunas G; CasZyme, 10224 Vilnius, Lithuania., Kalter N; Institute of Nanotechnology and Advanced Materials, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel., Gonçalves MAFV; Department of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the Netherlands., Petersen J; Steno Diabetes Center Aarhus, Aarhus University Hospital, 8200 Aarhus N, Denmark., Garanto A; Department of Pediatrics and Department of Human Genetics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands., Montoliu L; Department of Molecular and Cellular Biology, National Centre for Biotechnology (CNB-CSIC) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII), Madrid, Spain., Maresca M; Genome Engineering, Discovery Sciences, BioPharmaceuticals R&D Unit, AstraZeneca, Gothenburg, Sweden., Seemann SE; Center for Non-coding RNA in Technology and Health, Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark., Gorodkin J; Center for Non-coding RNA in Technology and Health, Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark., Mazini L; Laboratory of Genetic Engineering, Technologic, Medical and Academic Park (TMAP), Marrakech, Morocco., Sanchez R; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Department of Medicinal & Organic Chemistry and Excellence Research Unit of 'Chemistry Applied to Biomedicine and the Environment,' Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Universidad de Granada, Granada, Spain., Rodriguez-Madoz JR; Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain., Maldonado-Pérez N; Steno Diabetes Center Aarhus, Aarhus University Hospital, 8200 Aarhus N, Denmark., Laura T; DNA & RNA Medicine Division, Center for Applied Medical Research (CIMA) Universidad de Navarra, 31008 Pamplona, Spain., Schmueck-Henneresse M; Berlin Institute for Health (BIH) at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany., Maccalli C; Laboratory of Immune Biological Therapy, Research Branch, Sidra Medicine, PO Box 26999, Doha, Qatar., Grünewald J; Department of Medicine, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, TUM School of Medicine and Health, TranslaTUM, MIBE, Munich, Germany.; Center for Organoid Systems, Munich, Germany., Carmona G; Red Andaluza de diseño y traslación de Terapias Avanzadas-RAdytTA, Fundación Pública Andaluza Progreso y Salud-FPS, Sevilla, España., Kachamakova-Trojanowska N; Malopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland., Miccio A; Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, Université de Paris Cité, INSERM UMR 1163, 75015 Paris, France., Martin F; Bioquímica y Biología Molecular III e Immunology Department, Facultad de Medicina, Universidad de Granada and Department of Genomic Medicine, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), PTS, Av. de la Ilustración 114, 18016 Granada, Spain., Turchiano G; Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, WC1N 1EH London, UK., Cathomen T; Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, Freiburg, Germany.; Medical Faculty, University of Freiburg, 79106 Freiburg, Germany., Luo Y; Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark.; Steno Diabetes Center Aarhus, Aarhus University Hospital, 8200 Aarhus N, Denmark., Tsai SQ; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA., Benabdellah K; Department of Genomic Medicine, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), PTS, Av. de la Ilustración 114, 18016 Granada, Spain.

Publikováno v: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Oct 29; Vol. 34, pp. 102066. Date of Electronic Publication: 2023 Oct 29 (Print Publication: 2023).

Regulation of E2F1 activity via PKA-mediated phosphorylations.

Autor: Ertosun MG; Department of Plastic, Reconstructive, and Aesthetic Surgery, Faculty of Medicine, Akdeniz University, Antalya Turkey., DİlmaÇ S; Department of Histology and Embriology, Faculty of Medicine, Akdeniz University, Antalya Turkey., Hapİl FZ; Department of Medical Biology and Genetics, Faculty of Medicine, Akdeniz University, Antalya Turkey., TanriÖver G; Department of Histology and Embriology, Faculty of Medicine, Akdeniz University, Antalya Turkey., KÖksoy S; Department of Medical Microbiology, Faculty of Medicine, Akdeniz University, Antalya Turkey., ÖzeŞ ON; Altay Therapeutics, San Bruno, CA USA.

Publikováno v: Turkish journal of biology = Turk biyoloji dergisi [Turk J Biol] 2020 Oct 13; Vol. 44 (5), pp. 215-229. Date of Electronic Publication: 2020 Oct 13 (Print Publication: 2020).

Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.

Autor: Gorgisen G; Faculty of Medicine, Van Yuzuncu Yil University, Turkey., Hapil FZ; Izmir Biotechnology and Genome Center, Izmir, Turkey., Yilmaz O; Faculty of Medicine, Akdeniz University, Antalya, Turkey., Cetin Z; Faculty of Medicine, Sanko University, Gaziantep, Turkey., Pehlivanoglu S; Faculty of Science, Necmettin Erbakan University, Konya, Turkey., Ozbudak IH; Faculty of Medicine, Akdeniz University, Antalya, Turkey., Erdogan A; Faculty of Medicine, Akdeniz University, Antalya, Turkey., Ozes ON; ALTAY Biopharma, San Bruno, CA, USA.

Publikováno v: Genetics and molecular biology [Genet Mol Biol] 2019 Feb 25; Vol. 42 (1), pp. 15-25. Date of Electronic Publication: 2019 Feb 25 (Print Publication: 2019).

E2F1 transcription factor and its impact on growth factor and cytokine signaling.

Autor: Ertosun MG; Akdeniz University, Faculty of Medicine, Department of Medical Biology and Genetic, Kampus, Antalya 07070, Turkey., Hapil FZ; Akdeniz University, Faculty of Medicine, Department of Medical Biology and Genetic, Kampus, Antalya 07070, Turkey., Osman Nidai O; Akdeniz University, Faculty of Medicine, Department of Medical Biology and Genetic, Kampus, Antalya 07070, Turkey. Electronic address: osmanozes@gmail.com.

Publikováno v: Cytokine & growth factor reviews [Cytokine Growth Factor Rev] 2016 Oct; Vol. 31, pp. 17-25. Date of Electronic Publication: 2016 Mar 02.

Odour intensity learning in fruit flies.

Autor: Yarali A; Biozentrum, Universität Würzburg, Germany. yarali@neuro.mpg.de, Ehser S, Hapil FZ, Huang J, Gerber B

Publikováno v: Proceedings. Biological sciences [Proc Biol Sci] 2009 Oct 07; Vol. 276 (1672), pp. 3413-20. Date of Electronic Publication: 2009 Jul 08.